| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8485783 | Vaccine | 2018 | 11 Pages |
Abstract
More than 10â¯years after their introduction, available data confirm the benefits and acceptable safety profile of infant rotavirus UMV programmes. Europe serves to gain considerably from rotavirus UMV in terms of reductions in healthcare resource utilization and related costs in both vaccinated subjects and their unvaccinated siblings through herd protection.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Dirk Poelaert, Priya Pereira, Robert Gardner, Baudouin Standaert, Bernd Benninghoff,